Gateway Advisory, LLC Insulet Corp Transaction History

Gateway Advisory, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$272.48 - $330.23 $231,335 - $280,365	-849 Reduced 49.25%	875 $252,000
Q1 2023 May 12, 2023	SELL	$276.36 - $326.03 $151 Million - $179 Million	-548,163 Reduced 99.69%	1,724 $550,000
Q1 2023 May 11, 2023	BUY	$276.36 - $326.03 $152 Million - $179 Million	549,887 New	549,887 $550,000

685

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Gateway Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Gateway Advisory, LLC with notifications on news.